Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization (HITCH): A Multicenter, Phase 2 Randomized Controlled Trial of Best Supportive Care (BSC) vs BSC Plus Degarelix

NCT04397718 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04397718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization (HITCH): A Multicenter, Phase 2 Randomized Controlled Trial of Best Supportive Care (BSC) vs BSC Plus Degarelix
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Completed
Start date
July 6, 2020
Completion date
June 8, 2021
Enrollment
96 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19